Veterinary Radio-Frequency Identification (RFID) Medication Tracking Market Report 2026

The veterinary radio-frequency identification (RFID) medication tracking market size has grown rapidly in recent years. It will grow from $1.08 billion in 2025 to $1.23 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to manual medication tracking errors in veterinary clinics, lack of real-time inventory visibility in animal healthcare facilities, limited adoption of automated identification technologies, high medication misplacement and wastage rates, dependence on paper-based compliance systems.

The veterinary radio-frequency identification (RFID) medication tracking market size is expected to see rapid growth in the next few years. It will grow to $2.07 billion by 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to rising demand for automated veterinary supply chain management, increasing adoption of digital traceability systems, growing regulatory focus on medication accountability, expansion of smart veterinary hospital infrastructure, integration of IoT-enabled tracking systems in animal healthcare. Major trends in the forecast period include increasing adoption of rfid-enabled smart medication tracking systems for real-time veterinary pharmaceutical visibility, expansion of automated inventory reconciliation systems using radio-frequency tagging in animal healthcare facilities, growing integration of cloud-based medication traceability platforms with rfid infrastructure, rising deployment of error-free medication dispensing systems powered by rfid identification in veterinary hospitals, increasing use of rfid-based compliance monitoring solutions to reduce medication misuse and improve audit readiness.

The growth in livestock population is expected to propel the growth of the veterinary radio-frequency identification (RFID) medication tracking market going forward. Livestock population refers to the total number of domesticated farm animals such as cattle, sheep, goats, pigs, and poultry present within a specific geographic area at a given time. Livestock population is increasing primarily due to rising global demand for animal-based foods, as population growth and changing dietary preferences drive higher consumption of meat, milk, and other animal products. As livestock populations expand, managing medications across a large number of animals becomes more complex, increasing the need for veterinary radio-frequency identification (RFID) medication tracking to ensure accurate identification and proper treatment for each animal. For instance, in December 2025, according to the Department of Agriculture, global chicken meat production is projected to increase by about 2% in 2026, reaching a record 109.6 million tons. Additionally, US output is expected to grow by around 1% to 22 million tons. Therefore, the growth in livestock population is driving the growth of the veterinary radio-frequency identification (RFID) medication tracking market.

The expanding pet ownership is expected to propel the growth of the veterinary radio-frequency identification (RFID) medication tracking market going forward. A pet is an animal kept by humans primarily for companionship, emotional connection, or personal enjoyment rather than for economic or utilitarian purposes. Pet ownership is increasing due to rising social isolation and stress in modern lifestyles, encouraging more individuals to adopt animals as companions to enhance emotional well-being and reduce loneliness. As pet ownership increases, the number of veterinary visits and treatments also rises, creating a greater need for veterinary radio-frequency identification (RFID) medication tracking to ensure each animal is accurately identified and receives the appropriate medication. For instance, in March 2025, according to the American Pet Products Association, pet ownership has rebounded, with 94 million U. S. households owning at least one pet, up from 82 million in 2023, and overall ownership has increased for both dogs and cats, with dogs present in 51% of households (68 million) and cats in 37% (49 million). Therefore, the expanding pet ownership is driving the growth of the veterinary radio-frequency identification (RFID) medication tracking market.

The rising spending on companion animal healthcare is expected to propel the growth of the veterinary radio-frequency identification (RFID) medication tracking market going forward. Companion animal healthcare refers to the medical services and preventive care provided to pets such as dogs, cats, and other domesticated animals to maintain their health, diagnose conditions, and treat illnesses. Spending on companion animal healthcare is increasing due to the growing humanization of pets, as owners are more willing to invest in advanced medical treatments and preventive care to help their animals live longer and healthier lives. Higher spending on companion animal healthcare enables veterinary clinics to adopt advanced technologies such as radio-frequency identification (RFID) medication tracking systems, improving the accuracy and efficiency of medication management. For instance, in April 2025, according to the American Animal Hospital Association, spending on veterinary care, including pharmaceuticals and related products dispensed through veterinary clinics in the United States, was projected to total approximately $41.4 billion in 2025. Therefore, the rising spending on companion animal healthcare is driving the growth of the veterinary radio-frequency identification (RFID) medication tracking market.

Major companies operating in the veterinary radio-frequency identification (rfid) medication tracking market are Honeywell International Inc., Avery Dennison Corporation, Zebra Technologies Inc., HID Global Corp., Checkpoint Systems Inc., Brady Corporation, Datamars SA, Impinj Inc., Allflex USA Inc., CenTrak Inc., Invengo Technology Pte Ltd., Alien Technology Corp., GAO RFID Inc., WaveMark Inc., Terso Solutions Inc., GAO Tek Inc., Tageos, SATO Holdings Corporation, SML Group Ltd., Trovan Ltd.

North America was the largest region in the veterinary radio-frequency identification (RFID) medication tracking market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary radio-frequency identification (RFID) medication tracking market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary radio-frequency identification (RFID) medication tracking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary radio-frequency identification (RFID) medication tracking market consists of revenues earned by entities by providing services such as real-time medication tracking, automated medication identification, expiration date monitoring, and medication usage tracking. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary radio-frequency identification (RFID) medication tracking market also includes sales of ear tags, handheld RFID readers, fixed RFID readers, and RFID smart labels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.